UnitedHealth, UNH and Stocks
Digest more
Down 50% from all-time highs, UnitedHealth is an S&P 500 stock that is gaining attention from noted investors such as Michael Burry in 2025.
1d
TipRanks on MSNWhy Is Bernstein Analyst Cautious on UNH Stock?
UnitedHealth Group ($UNH) stock continues to be under pressure, down more than 50% since mid-April. Wall Street remains concerned about the health
UnitedHealth Group (UNH) shares soared 12% on August 15, 2025, after Warren Buffetts Berkshire Hathaway revealed a $1.6 billion stake of over 5 million shares. The surge marks the stocks biggest jump in five years,
One way UnitedHealth puts its excess cash to work is by paying -- and steadily growing -- its dividend payment. This is a feature that Buffett undoubtedly appreciates. Known for his unwavering patience, Buffett often holds on to core positions for years, if not decades.
15h
TipRanks on MSNBuffett’s Endorsement Isn’t Enough to Sway Bank of America on UNH Stock
UnitedHealth (NYSE:UNH) stock grabbed headlines last week, as Warren Buffett – the legendary Oracle of Omaha – disclosed a $1.6 billion stake, a
If UNH were to drop to a valuation level of around 10 times its earnings, the stock could theoretically dip to about $160 — indicating an additional 36% fall from current prices.
Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008.
UnitedHealth Group (NYSE: UNH) is a top health care stock with recent turbulence in earnings guidance, rising costs, and hedge fund activity.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
5d
TipRanks on MSNCVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
CVS Health (CVS) and UnitedHealth Group (UNH), two of the largest players in the healthcare sector, recently reported their Q2 earnings, showing contrasting performances. While CVS delivered strong revenue growth and raised its full-year guidance,